Beneficial Effects of Probiotic Bifidobacterium and Galacto-Oligosaccharide in Patients with Ulcerative Colitis: A Randomized Controlled Study

Probiotics in man and animals

AFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,831

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285

Synbiotic therapy ( Bifidobacterium longum /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., Simone, C. D., & Sartor, R. B. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41794.x · Cited by 743

Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis

Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02268.x · Cited by 397

G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation

Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Rabe, B., Chalaris, A., Scheller, J., Rehmann, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900063 · Cited by 385

A pilot trial of Saccharomyces boulardii in ulcerative colitis

Guslandi, M., Giollo, P., & Testoni, P. A. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200306000-00017 · Cited by 383

Randomized Controlled Trial of the Effect of Bifidobacteria-Fermented Milk on Ulcerative Colitis

Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A., & Otani, T. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719276 · Cited by 369

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

Kitajima, H., Sumida, Y., Tanaka, R., Yuki, N., Takayama, H., & Fujimura, M. (1997) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.76.2.f101 · Cited by 315

THE VALUE OF RECTAL BIOPSY IN THE DIAGNOSIS OF ULCERATIVE COLITIS1

Matts, S. G. F. (1961) · QJM · doi:10.1093/oxfordjournals.qjmed.a066953 · Cited by 311

Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells

Imaoka, A., Shima, T., Kato, K., Mizuno, S., Uehara, T., Matsumoto, S., Setoyama, H., Hara, T., & Umesaki, Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2511 · Cited by 179

Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid

Watanabe, T., Nishio, H., Tanigawa, T., Yamagami, H., Okazaki, H., Watanabe, K., Tominaga, K., Fujiwara, Y., Oshitani, N., Asahara, T., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90553.2008 · Cited by 160

Colitis in transgenic and knockout animals as models of human inflammatory bowel disease

Bhan, A. K., Mizoguthi, E., Smith, R. N., & Mizoguchi, A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01316.x · Cited by 151

Characterization of antibody responses against rectal mucosa‐associated bacterial flora in patients with ulcerative colitis

Matsuda, H., Fujiyama, Y., Andoh, A., Ushijima, T., Kajinami, T., & Bamba, T. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02045.x · Cited by 133

Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis

Carlson, M., Raab, Y., Sevéus, L., Xu, S., Hällgren, R., & Venge, P. (2002) · Gut · doi:10.1136/gut.50.4.501 · Cited by 129

Improved medium for selective isolation and enumeration of Bifidobacterium

Tanaka, R., & Mutai, M. (1980) · Applied and Environmental Microbiology · doi:10.1128/aem.40.5.866-869.1980 · Cited by 108

Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients

Setoyama, H., Imaoka, A., Ishikawa, H., & Umesaki, Y. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00080-1 · Cited by 106

Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy

Tsuda, Y., Yoshimatsu, Y., Aoki, H., Nakamura, K., Irie, M., Fukuda, K., Hosoe, N., Takada, N., Shirai, K., & Suzuki, Y. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701396091 · Cited by 73

Immune Networks in Animal Models of Inflammatory Bowel Disease

Mizoguchi, A., Mizoguchi, E., & Bhan, A. K. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00005 · Cited by 72

Preventive Effects of Bifidobacterium- and Lactobacillus-Fermented Milk on the Development of Inflammatory Bowel Disease in Senescence-Accelerated Mouse P1/Yit Strain Mice

Matsumoto, S., Watanabe, N., Imaoka, A., & Okabe, Y. (2001) · Digestion · doi:10.1159/000048846 · Cited by 72

Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus

Onderdonk, A. B., Cisneros, R. L., & Bronson, R. T. (1983) · Infection and Immunity · doi:10.1128/iai.42.2.783-788.1983 · Cited by 55

Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis

Onderdonk, A. B., Bronson, R. T., & Cisneros, R. L. (1987) · Infection and Immunity · doi:10.1128/iai.55.3.835-836.1987 · Cited by 45

Antibodies detectable by counterimmunoelectrophoresis against Bacteroides antigens in serum of patients with inflammatory bowel disease

Helphingstine, C. J., Hentges, D. J., Campbell, B. J., Butt, J. H., & Barrett, J. T. (1979) · Journal of Clinical Microbiology · doi:10.1128/jcm.9.3.373-378.1979 · Cited by 19

[Assessment of probiotics according to the international organizations (FAO/WHO)].

Tm, L., & Vs, P. (2006) · PubMed · Cited by 12

Bifidobacteria and Their Role as Members of the Human Gut Microbiota

O’Callaghan, A. A., & van Sinderen, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00925 · Cited by 1,160

Actinobacteria: A relevant minority for the maintenance of gut homeostasis

Binda, C., Lopetuso, L. R., Rizzatti, G., Gibiino, G., Cennamo, V., & Gasbarrini, A. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.02.012 · Cited by 828

Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome

Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533

P0896 A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the efficacy of a synbiotic formulation in modulating gut microbiota biodiversity in patients with mild-to-moderate UC in clinical and endoscopic remission

Murgiano, M., Bartocci, B., Gaudio, A. D., Rozera, T., Puca, P., Parisio, L., Mignini, I., Coppola, G., Biasio, F. D., Lavigna, D., et al. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae190.1070

A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the role of a L. rhamnosus GG-based symbiotic formulation in patients with mild-to-moderate uc in clinical and endoscopic remission

Lopetuso, L., Murgiano, M., Bartocci, B., Rozera, T., GAUDIO, A. D., Puca, P., Parisio, L., Coppola, G., Laterza, L., Pugliese, D., et al. (2025) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.26355/mhd_20259_1343

Synbiotic therapy ( Bifidobacterium longum /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766

Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study

ALTUN, H. K., Yıldız, E. A., & Akın, M. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18356 · Cited by 70

Synbiotic supplementation containing Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis

Sheng, K., He, S., Sun, M., Zhang, G., Kong, X., Wang, J., & Wang, Y. (2020) · Food & Function · doi:10.1039/d0fo00518e · Cited by 102